Forbes

The therapy is a brand new targeted drug for the disease which experts have labelled as a substantial breakthrough following doubling of survival time in a trial.

Hospitals are grappling with rising, unpredictable AI costs, driven by "tokens", the sub-word units processed by large language models.

Engineered regulatory T cells that recognize birch pollen reduced allergic airway inflammation in mice, hinting at a future cell therapy for severe allergies.

Radial bought Mindful Health Solutions, expanding the market for accelerated TMS, Spravato, Ketamine, focused ultrasound, psilocybin, and other emerging treatments

Concert pianist and molecular biochemist, Dr. Mei Rui, is transforming Music Medicine at MD Anderson.

A new BMJ study offers the first population-based CTE prevalence estimate for NFL players, finding a minimum of 25% among those who died from 2016-2021.

AI models are built to please, sometimes at the expense of accuracy. Now billions are flowing into the companies and technology designed to detect and curb AI sycophancy.

A two-antibody click-chemistry strategy improves targeted chemotherapy delivery to resistant HER2- and EGFR-positive tumors, boosting tumor control in mice.

The Trump administration has been progressively shrinking AHRQ, the only federal agency focused on supporting research to improve the safety and quality of healthcare.